541 related articles for article (PubMed ID: 16336453)
41. Clinical significance of circulating galectins as colorectal cancer markers.
Watanabe M; Takemasa I; Kaneko N; Yokoyama Y; Matsuo E; Iwasa S; Mori M; Matsuura N; Monden M; Nishimura O
Oncol Rep; 2011 May; 25(5):1217-26. PubMed ID: 21369702
[TBL] [Abstract][Full Text] [Related]
42. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
Yuksel BC; Yildiz Y; Ozturk B; Berkem H; Katman U; Ozel H; Hengirmen S
Am J Surg; 2008 Apr; 195(4):452-6. PubMed ID: 18083135
[TBL] [Abstract][Full Text] [Related]
43. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer.
Japink D; Leers MP; Sosef MN; Nap M
Anticancer Res; 2009 Aug; 29(8):3245-51. PubMed ID: 19661342
[TBL] [Abstract][Full Text] [Related]
44. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017
[TBL] [Abstract][Full Text] [Related]
45. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
46. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Lopez JB; Balasegaram M; Timor J; Thambyrajah V
Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
[TBL] [Abstract][Full Text] [Related]
47. Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III.
Hara M; Sato M; Takahashi H; Takayama S; Takeyama H
J Surg Oncol; 2010 Aug; 102(2):154-7. PubMed ID: 20648586
[TBL] [Abstract][Full Text] [Related]
48. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
49. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
Zhao Z; Xiao Y; Elson P; Tan H; Plummer SJ; Berk M; Aung PP; Lavery IC; Achkar JP; Li L; Casey G; Xu Y
J Clin Oncol; 2007 Jul; 25(19):2696-701. PubMed ID: 17602074
[TBL] [Abstract][Full Text] [Related]
50. [Significance of carcinoembryonic antigen levels in peritoneal washings in clinical analysis of patients with colorectal cancer].
Bała D; Jawień A; Czechowicz W; Banaszkiewicz Z; Kaźmierczak M; Ciecierski M
Pol Merkur Lekarski; 2002 Oct; 13(76):289-93. PubMed ID: 12557433
[TBL] [Abstract][Full Text] [Related]
51. Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels.
Wang JY; Lin SR; Wu DC; Lu CY; Yu FJ; Hsieh JS; Cheng TL; Koay LB; Uen YH
Clin Cancer Res; 2007 Apr; 13(8):2406-13. PubMed ID: 17406027
[TBL] [Abstract][Full Text] [Related]
52. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
Jiang XT; Tao HQ; Zou SC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
[TBL] [Abstract][Full Text] [Related]
53. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
Iarŭmov N; Ignatov A; Viiachki I
Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
[TBL] [Abstract][Full Text] [Related]
54. The effect of colonoscopy on tumor markers.
Scapa E; Broide E; Pinhasov I
Surg Laparosc Endosc; 1997 Dec; 7(6):477-9. PubMed ID: 9438630
[TBL] [Abstract][Full Text] [Related]
55. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
[TBL] [Abstract][Full Text] [Related]
57. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
58. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
[TBL] [Abstract][Full Text] [Related]
59. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer.
Yakabe T; Nakafusa Y; Sumi K; Miyoshi A; Kitajima Y; Sato S; Noshiro H; Miyazaki K
Ann Surg Oncol; 2010 Sep; 17(9):2349-56. PubMed ID: 20217258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
